Clinical Trial Update: An Observational Study of Chinese Multiple Myeloma Patients Treated With Velcade

View source ↗

Summary

This document notes the completion of an observational study assessing Velcade (bortezomib) in Chinese patients with multiple myeloma. The trial was sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Multiple Myeloma | Status: COMPLETED